Skip to content
★ Sign in to follow
中化

中化生 Stock: price and insider trades · Taiwan

TW·Mcap NT$2.7BHealth Care

中化生: what insiders have been doing

We have very little insider data for 中化生 so far: the most recent filing dates from 23 November 2021. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 23,715 of 26,911 companies
23.7
score / 100
Value
36
Quality
11
FCF yld3.0%
Earn yld-9.1%
EV/EBITDA·
ROE-1.6%
Gross mgn-1.1%
Net mgn-30%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

NT$35
Analyst consensus
·
Income statement
RevenueNT$804.9M
Gross profit-NT$8.9M-1% margin
EBITDA-NT$47.6M-6% margin
Net income-NT$243.8M-5.5% margin
Valuation
P/Book0.8x
Beta0.51
Balance sheet & cash
Market capNT$2.7B
Total debtNT$805.9M
Free Cash FlowNT$80.3M
Debt / Equity24%
Profitability & ownership
ROE-1.6%
ROA-1.9%
% insiders41.3%
% institutions0.7%
Last declaration on 23 November 2021
Declarations2 total
  • ●
    Related company / holdingExecutives
    €800kest.0MOPS
    400,000 sharesShareTWSETWMOPS:1762:110/11/23:中國化學製藥股份有限公司之配偶:0mj22zw
  • ●
    DirectorExecutives
    €26kest.0MOPS
    13,000 sharesShareTWSETWMOPS:1762:110/11/23:王謝怡貞:01wlrqt

2 of 2 declarations

About 中化生

中化生 is a company listed on the XTAI market, specializing in the chemical and chemical products sector. It focuses on the production and distribution of various chemical products for different industries.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations